1. Home
  2. CNMD vs NVAX Comparison

CNMD vs NVAX Comparison

Compare CNMD & NVAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CONMED Corporation

CNMD

CONMED Corporation

HOLD

Current Price

$35.95

Market Cap

1.2B

Sector

Health Care

ML Signal

HOLD

Logo Novavax Inc.

NVAX

Novavax Inc.

HOLD

Current Price

$9.44

Market Cap

1.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CNMD
NVAX
Founded
1970
1987
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
1.6B
IPO Year
1995
1996

Fundamental Metrics

Financial Performance
Metric
CNMD
NVAX
Price
$35.95
$9.44
Analyst Decision
Hold
Hold
Analyst Count
6
9
Target Price
$48.00
$11.33
AVG Volume (30 Days)
381.5K
4.4M
Earning Date
04-29-2026
05-07-2026
Dividend Yield
1.09%
N/A
EPS Growth
N/A
309.76
EPS
1.51
2.58
Revenue
$1,374,724,000.00
$1,123,479,000.00
Revenue This Year
$0.82
N/A
Revenue Next Year
$5.48
N/A
P/E Ratio
$24.37
$3.77
Revenue Growth
5.18
64.69
52 Week Low
$35.37
$5.01
52 Week High
$61.25
$11.85

Technical Indicators

Market Signals
Indicator
CNMD
NVAX
Relative Strength Index (RSI) 26.64 46.76
Support Level $35.37 $9.14
Resistance Level $46.08 $10.42
Average True Range (ATR) 1.42 0.60
MACD -0.56 -0.13
Stochastic Oscillator 2.77 16.52

Price Performance

Historical Comparison
CNMD
NVAX

About CNMD CONMED Corporation

Conmed Corp is a medical technology company that provides devices and equipment for surgical procedures. The company's products are used by surgeons and other healthcare professionals across specialties, including orthopedics, general surgery, gynecology, thoracic surgery, and gastroenterology. Geographically, the company operates in the United States, Europe, the Middle East & Africa, Asia Pacific, and the Americas, excluding the United States. The majority of revenue is generated from the United States.

About NVAX Novavax Inc.

Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. It works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The company manages its business as one operating segment, an in-house early-stage R&D business to build a pipeline of high-value assets using its technology along with seeking to enter into partnerships to drive value creation for its assets.

Share on Social Networks: